title: [Reversible posterior leukoencephalopathy. A new syndrome or a new name for an old syndrome?].
abstract: BACKGROUND
  Reversible posterior leucoencephalopathy syndrome is a recently proposed cliniconeuroradiologic category characterized by seizures, disorders of consciousness, visual abnormalities and headaches associated with predominantly posterior white matter abnormalities on CT and MRI examinations.
  Since the initial description, reversible posterior leucoencephalopathy has been recognized in an increasing number of medical conditions, including hypertensive encephalopathy, eclampsia, and immunosuppressive treatment. The rapid resolution of clinical and neuroradiologic abnormalities suggests cerebral edema which is thought to result from impaired cerebrovascular autoregulation and endothelial injury.
  
  
  CONCLUSIONS
  Whereas reversibility of the posterior leucoencephalopathy is a characteristic of the disorder, this reversibility is contingent on prompt controlling blood pressure and discontinuing the offending immunosuppressive drug.
authors: Service de Neurologie, Hôpital Sainte-Anne, 1, rue Cabanis, F 75674 Paris. lamy@chsa.broca.inserm.fr
authors: C
authors: C
authors: Lamy
authors: J L
authors: JL
authors: Mas
mesh_terms: D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000175:diagnosis* / Q000209:etiology; D003937:Diagnosis, Differential; D004461:Eclampsia / Q000175:diagnosis; D005260:Female; D006801:Humans; D020343:Hypertensive Encephalopathy / Q000175:diagnosis; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008279:Magnetic Resonance Imaging; D008297:Male; D019636:Neurodegenerative Diseases / Q000175:diagnosis* / Q000209:etiology; D011247:Pregnancy; D013577:Syndrome; D014057:Tomography, X-Ray Computed
chemical_list: D007166:Immunosuppressive Agents